BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel RB, Vaduganathan M, Samman-Tahhan A, Kalogeropoulos AP, Georgiopoulou VV, Fonarow GC, Gheorghiade M, Butler J. Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials. Am J Cardiol 2016;117:1845-50. [PMID: 27085935 DOI: 10.1016/j.amjcard.2016.03.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Miller LW. Cardiac Ejection Fraction: New Insights About its Dynamic Nature. J Am Coll Cardiol 2018;72:602-4. [PMID: 30071988 DOI: 10.1016/j.jacc.2018.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Rodríguez-leor O, Cid-álvarez AB, Moreno R, Pérez de Prado A. Selección de lo mejor del año 2018 en denervación simpática renal en el tratamiento de la hipertensión arterial. REC: CardioClinics 2019;54:51-7. [DOI: 10.1016/j.rccl.2019.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Sepehrvand N, Alemayehu W, Ezekowitz JA. Pragmatic vs Explanatory Trials-Reply. JAMA Cardiol 2020;5:488. [PMID: 32074246 DOI: 10.1001/jamacardio.2019.6114] [Reference Citation Analysis]
4 Greene SJ, Mentz RJ, Fiuzat M, Butler J, Solomon SD, Ambrosy AP, Mehta C, Teerlink JR, Zannad F, O'Connor CM. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure. Circulation 2018;138:1039-53. [PMID: 30354535 DOI: 10.1161/CIRCULATIONAHA.118.034668] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
5 Bovbjerg ML, Dissanayake MV, Cheyney M, Brown J, Snowden JM. Utility of the 5-Minute Apgar Score as a Research Endpoint. Am J Epidemiol 2019;188:1695-704. [PMID: 31145428 DOI: 10.1093/aje/kwz132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Navasardyan AR, Martsevich SY. Endpoints: types, selection, interpretation of the results obtained on the example of cardiology studies. Cardiovasc Ther Prev 2022;21:3243. [DOI: 10.15829/1728-8800-2022-3243] [Reference Citation Analysis]
7 Secemsky EA, Ferro EG, Rao SV, Kirtane A, Tamez H, Zakroysky P, Wojdyla D, Bradley SM, Cohen DJ, Yeh RW. Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry. JAMA Cardiol 2019;4:110-8. [PMID: 30624549 DOI: 10.1001/jamacardio.2018.4472] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
8 Butler J, Hamo CE, Udelson JE, O'Connor C, Sabbah HN, Metra M, Shah SJ, Kitzman DW, Teerlink JR, Bernstein HS, Brooks G, Depre C, DeSouza MM, Dinh W, Donovan M, Frische-Danielson R, Frost RJ, Garza D, Gohring UM, Hellawell J, Hsia J, Ishihara S, Kay-Mugford P, Koglin J, Kozinn M, Larson CJ, Mayo M, Gan LM, Mugnier P, Mushonga S, Roessig L, Russo C, Salsali A, Satler C, Shi V, Ticho B, van der Laan M, Yancy C, Stockbridge N, Gheorghiade M. Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations. Circ Heart Fail 2017;10:e003800. [PMID: 28356300 DOI: 10.1161/CIRCHEARTFAILURE.116.003800] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
9 Bovbjerg ML, Cheyney M. Current Resources for Evidence-Based Practice, July 2020. J Obstet Gynecol Neonatal Nurs 2020;49:391-404. [PMID: 32574584 DOI: 10.1016/j.jogn.2020.06.002] [Reference Citation Analysis]